Clinical Study
Association of One-Step Nucleic Acid Amplification Detected Micrometastases with Tumour Biology and Adjuvant Chemotherapy
Table 1
Demographic and tumour characteristics.
| | | Pre-OSNA | Post-OSNA | | | (2009–2012) | (2013) |
| | Number of patients (n/%) | 36 (47.4%) | 40 (52.6%) | | Age (range) | 57 (39–74) | 60 (32–76) | | Screen detected | 12 (33.3%) | 21 (52.5%) | | Tumour size (mm) | 25.9 | 18.3 | | Tumour grade (n/%) | | | | Grade 1 | 5 (14%) | 2 (5%) | | Grade 2 | 18 (50%) | 21 (52.5%) | | Grade 3 | 13 (36%) | 17 (42.5%) | | ER receptor (n/%) | | | | Positive | 31 (86%) | 28 (70%) | | Negative | 5 (14%) | 11 (27.5%) | | Borderline | 0 | 1 (2.5%) | | HER-2 receptor (n/%) | | | | Positive | 6 (16.6%) | 6 (15%) | | Negative | 30 (83.3%) | 34 (85%) | | Triple negative (n/%) | 6 (16.6%) | 8 (20%) |
|
|
